Virus | hA3G | Trial 1 | Trial 2 | Ave ± Std | |||
---|---|---|---|---|---|---|---|
IU/ml* | Relative infectivity** | IU/ml | Relative infectivity | IU/ml | Relative infectivity | ||
VP62 | - | 1.7 X 104 | 1 | 1.4 X 104 | 1 | 1.5 X 104 ± 2.3 X 103 | 0.209 ± 0.029 |
 | + | 3.2 X 103 | 0.188 | 3.2 X 103 | 0.229 | 3.2 X 103 ± 3.3 X 101 |  |
VP62Δgg0 | - | 8.4 X 103 | 1 | 1.2 X 104 | 1 | 1.0 X 104 ± 2.3 X 103 | 0.196 ± 0.058 |
 | + | 1.3 X 103 | 0.155 | 2.8 X 103 | 0.237 | 2.0 X 103 ± 1.1 X 103 |  |
VP62Δgg1 | - | 1.2 X 103 | 1 | 3.4 X 103 | 1 | 2.3 X 103 ± 1.5 X 103 | 0.240 ± 0.014 |
 | + | 3.0 X 102 | 0.250 | 7.7 X 102 | 0.230 | 5.4 X 102 ± 3.3 X 102 |  |
VP62Δgg2 | - | 1.8 X 104 | 1 | 9.1 X 103 | 1 | 1.3 X 104 ± 6.0 X 103 | 0.234 ± 0.010 |
 | + | 4.0 X 103 | 0.227 | 2.2 X 103 | 0.241 | 3.1 X 103 ± 1.3 X 103 |  |
VP62Δgg3 | - | 1.1 X 104 | 1 | 8.2 X 103 | 1 | 9.5 X 103 ± 1.8 X 103 | 0.214 ± 0.068 |
 | + | 2.8 X 103 | 0.262 | 1.4 X 103 | 0.165 | 2.1 X 103 ± 1.0 X 103 |  |
VP62Δgg4 | - | 2.2 X 104 | 1 | 1.3 X 104 | 1 | 1.7 X 104 ± 6.2 X 103 | 0.258 ± 0.049 |
 | + | 6.4 X 103 | 0.292 | 2.9 X 103 | 0.223 | 4.7 X 103 ± 2.5 X 103 |  |